Therapeutic potential of ectopic olfactory and taste receptors

Nature Reviews Drug Discovery

Volumn 18, Issue 2, 2019, Pages 116-138

  Lee, Sung Joon ^a   Depoortere, Inge ^b   Hatt, Hanns ^c  

^a Korea University   (South Korea)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FREE FATTY ACID RECEPTOR 2; FREE FATTY ACID RECEPTOR 3; FREE FATTY ACID RECEPTOR 4; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 40; TASTE RECEPTOR FAMILY 1; TASTE RECEPTOR FAMILY 2; UNCLASSIFIED DRUG;

ADIPOGENESIS; ASTHMA; BLOOD PRESSURE REGULATION; BRONCHOCONSTRICTION; CHEMOTAXIS; ECTOPIC EXPRESSION; FOOD INTAKE; GASTROINTESTINAL TRACT; HAIR GROWTH; HEART RATE; HUMAN; HYPOPIGMENTATION; HYPOXIA; IMMUNITY; INFLAMMATION; KIDNEY FUNCTION; LIPID METABOLISM; LIVER METABOLISM; MALIGNANT NEOPLASM; NONHUMAN; OBESITY; OLFACTORY RECEPTOR; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SPERM; SUBCUTANEOUS FAT; TASTE BUD; WOUND HEALING; ANIMAL; INNERVATION; NERVE TRACT; OLFACTORY MUCOSA; OLFACTORY RECEPTOR NEURON; PHYSIOLOGY; TASTE;

ANIMALS; HUMANS; NEURAL PATHWAYS; OLFACTORY MUCOSA; OLFACTORY RECEPTOR NEURONS; TASTE; TASTE BUDS;

EID: 85057608290     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/s41573-018-0002-3     Document Type: Review

References (317)

1. Silva Teixeira, C. S., Cerqueira, N. M. & Silva Ferreira, A. C. Unravelling the olfactory sense: from the gene to odor perception. Chem. Senses 41, 105–121 (2016). This is a comprehensive review of the role played by ORs and associated signalling pathways in sensory olfactory neurons.
2. Wackermannova, M., Pinc, L. & Jebavy, L. Olfactory sensitivity in mammalian species. Physiol. Res. 65, 369–390 (2016).
3. Breslin, P. A. S. An evolutionary perspective on food and human taste. Curr. Biol. 23, R409–R418 (2013).
4. Dalton, R. P. & Lomvardas, S. Chemosensory receptor specificity and regulation. Annu. Rev. Neurosci. 38, 331–349 (2015).
5. Ihara, S., Yoshikawa, K. & Touhara, K. Chemosensory signals and their receptors in the olfactory neural system. Neuroscience 254, 45–60 (2013).
6. Feldmesser, E. et al. Widespread ectopic expression of olfactory receptor genes. BMC Genomics 7, 121 (2006). This study systematically profiles OR gene expression in different tissues, which express specific, relatively small OR gene subsets at particularly high levels, and suggests that such small OR subsets may play functional roles in different tissues.
7. Flegel, C., Manteniotis, S., Osthold, S., Hatt, H. & Gisselmann, G. Expression profile of ectopic olfactory receptors determined by deep sequencing. PLOS ONE 8, e55368 (2013). This study uses next-generation sequencing to perform comprehensive RNA-seq experiments investigating the ectopic OR profiles of 16 human tissues. All tissues examined express at least some ORs, and several ORs such as OR2W3 and OR51E1 are widely distributed. OR4N4 is shown to be specifically expressed in the testis.
8. Steensels, S. & Depoortere, I. Chemoreceptors in the gut. Annu. Rev. Physiol. 80, 117–141 (2017). This is a comprehensive review of the role played by taste receptors in enteroendocrine cells of the gut.
9. Spehr, M. et al. Identification of a testicular odorant receptor mediating human sperm chemotaxis. Science 299, 2054–2058 (2003). This is the first study to prove the functionality of an OR located outside the nose. In this study, OR1D2 is reported to be highly expressed in human spermatozoa and is activated by the odorant bourgeonal, eliciting positive chemotactic and chemokinetic swimming behaviour by spermatozoa.
10. Busse, D. et al. A synthetic sandalwood odorant induces wound-healing processes in human keratinocytes via the olfactory receptor OR2AT4. J. Invest. Dermatol. 134, 2823–2832 (2014). This study is the first to investigate the role of an OR in skin keratinocytes. OR2AT4 activation by Sandalore is shown to induce wound healing by stimulating keratinocyte proliferation via activation of ERK1, ERK2 and p30 in ex vivo human skin. Novel wound-healing therapeutics were developed on the basis of these findings.
11. Tsai, T. et al. Two olfactory receptors-OR2A4/7 and OR51B5-differentially affect epidermal proliferation and differentiation. Exp. Dermatol. 26, 58–65 (2017).
12. Cheret, J. et al. Hair follicles engage in chemosensation: olfactory receptor OR2AT4 regulates human hair growth. Nat. Commun. 9, 3624 (2018). This study demonstrates the functionality of OR2AT4 in human hair growth. OR2AT4 is expressed in the human hair follicles, and activation by Sandalore prolongs the active growth phase of hair by inducing the expression of IGF1. Results from the preliminary test on humans support the findings from ex vivo culture of human follicles.
13. Griffin, C. A., Kafadar, K. A. & Pavlath, G. K. MOR23 promotes muscle regeneration and regulates cell adhesion and migration. Dev. Cell 17, 649–661 (2009). This study investigates the role played by the mouse OR OLFR16 (MOR23) in skeletal muscle. In this study, the receptor stimulates skeletal muscle regeneration by inducing myocyte migration and adhesion, thus contributing to tissue repair.
14. Weber, L. et al. Activation of odorant receptor in colorectal cancer cells leads to inhibition of cell proliferation and apoptosis. PLOS ONE 12, e0172491 (2017).
15. Kalbe, B. et al. Helional-induced activation of human olfactory receptor 2J3 promotes apoptosis and inhibits proliferation in a non-small-cell lung cancer cell line. Eur. J. Cell Biol. 96, 34–46 (2017).
16. Massberg, D. et al. The activation of OR51E1 causes growth suppression of human prostate cancer cells. Oncotarget 7, 48231–48249 (2016).
17. Neuhaus, E. M. et al. Activation of an olfactory receptor inhibits proliferation of prostate cancer cells. J. Biol. Chem. 284, 16218–16225 (2009).
18. Manteniotis, S. et al. Functional characterization of the ectopically expressed olfactory receptor 2AT4 in human myelogenous leukemia. Cell Death Discov. 2, 15070 (2016). This study is the first to describe an OR-mediated pathway in human myelogenous leukaemia cells; the pathway is shown to regulate cell proliferation, apoptosis and differentiation after stimulation of OR2AT4 with an odorant.
19. Wu, C. et al. Olfactory receptor 544 reduces adiposity by steering fuel preference toward fats. J. Clin. Invest. 127, 4118–4123 (2017). This study is the first to investigate the role played by ectopic ORs in obesity and energy metabolism in vivo. In this study, OLFR544 activation by azelaic acid reduces adiposity via induction of fatty acid oxidation, thermogenesis and lipolysis in the liver, brown adipose tissue and white adipose tissue, respectively.
20. Calvo, S. S. & Egan, J. M. The endocrinology of taste receptors. Nat. Rev. Endocrinol. 11, 213–227 (2015).
21. Depoortere, I. Taste receptors of the gut: emerging roles in health and disease. Gut 63, 179–190 (2014).
22. Devillier, P., Naline, E. & Grassin-Delyle, S. The pharmacology of bitter taste receptors and their role in human airways. Pharmacol. Ther. 155, 11–21 (2015).
23. Suckow, A. T. & Briscoe, C. P. Key questions for translation of FFA receptors: from pharmacology to medicines. Handb. Exp. Pharmacol. 236, 101–131 (2017).
24. Hutchings, C. J., Koglin, M., Olson, W. C. & Marshall, F. H. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors. Nat. Rev. Drug Discov. 16, 787–810 (2017).
25. Gelis, L. et al. Functional characterization of the odorant receptor 51E2 in human melanocytes. J. Biol. Chem. 291, 17772–17786 (2016). This study examines the role played by OR51E2 in melanogenesis. In this study, activation of the receptor by β-ionone is shown to reduce melanogenesis and increase the levels of cAMP and intracellular calcium, and cell proliferation is inhibited by receptor activation.
26. Weber, L. et al. Characterization of the olfactory receptor OR10H1 in human urinary bladder cancer. Front. Physiol. 9, 456 (2018).
27. Xu, L. L. et al. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. Cancer Res. 60, 6568–6572 (2000).
28. Xu, L. L. et al. Quantitative expression profile of PSGR in prostate cancer. Prostate Cancer Prostat. Dis. 9, 56–61 (2006).
29. Rigau, M. et al. PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine. Prostate 70, 1760–1767 (2010).
30. Sanz, G. et al. Promotion of cancer cell invasiveness and metastasis emergence caused by olfactory receptor stimulation. PLOS ONE 9, e85110 (2014).
31. Cao, W. Q., Li, F. Q., Yao, J. G. & Yu, J. Z. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion. BMC Cancer 15, 915 (2015).
32. Weng, J. et al. PSGR2, a novel G-protein coupled receptor, is overexpressed in human prostate cancer. Int. J. Cancer 118, 1471–1480 (2006).
33. Xia, C., Ma, W., Wang, F., Hua, S. & Liu, M. Identification of a prostate-specific G-protein coupled receptor in prostate cancer. Oncogene 20, 5903–5907 (2001).
34. Weber, L. et al. Olfactory receptors as biomarkers in human breast carcinoma tissues. Front. Oncol. 8, 33 (2018).
35. Ranzani, M. et al. Revisiting olfactory receptors as putative drivers of cancer. Wellcome Open Res. 2, 9 (2017).
36. Avau, B. et al. The gustatory signaling pathway and bitter taste receptors affect the development of obesity and adipocyte metabolism in mice. PLOS ONE 10, e0145538 (2015).
37. Kim, K. S., Egan, J. M. & Jang, H. J. Denatonium induces secretion of glucagon-like peptide-1 through activation of bitter taste receptor pathways. Diabetologia 57, 2117–2125 (2014).
38. Cartoni, C. et al. Taste preference for fatty acids is mediated by GPR40 and GPR120. J. Neurosci. 30, 8376–8382 (2010).
39. Mattes, R. D. Accumulating evidence supports a taste component for free fatty acids in humans. Physiol. Behav. 104, 624–631 (2011).
40. Zhang, Y. Y., Liu, W., Zhao, T. Y. & Tian, H. M. Efficacy of omega-3 polyunsaturated fatty acids supplementation in managing overweight and obesity: a meta-analysis of randomized clinical trials. J. Nutr. Health Aging 21, 187–192 (2017).
41. Deshpande, D. A. et al. Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat. Med. 16, 1299–1304 (2010). This study shows that aerosol administration of bitter substances may induce bronchodilation in patients with asthma by activating bitter taste receptors in human airway smooth muscles.
42. Lee, R. J. et al. Bitter and sweet taste receptors regulate human upper respiratory innate immunity. J. Clin. Invest. 124, 1393–1405 (2014). In this study, targeting of a sweet taste receptor is shown to inhibit bitter taste receptor-induced antimicrobial peptide production in the upper airway and may aid in the treatment of upper respiratory tract infections.
43. Lee, R. J. et al. T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection. J. Clin. Invest. 122, 4145–4159 (2012). In this study, genetic variation of the bitter taste receptor TAS2R38 is shown to regulate the innate defence mechanism against quorum-sensing molecules secreted by Gram-negative bacteria in the epithelia of the human upper airway.
44. Buck, L. & Axel, R. A novel multigene family may encode odorant receptors — a molecular-basis for odor recognition. Cell 65, 175–187 (1991). This paper reports the discovery of ORs in rat olfactory epithelium and is a major breakthrough in work on olfaction. In this paper, 18 different members of an extremely large multigene family were cloned and characterized, which encodes seven transmembrane domain proteins whose expression is restricted to the olfactory epithelium.
45. Aloni, R., Olender, T. & Lancet, D. Ancient genomic architecture for mammalian olfactory receptor clusters. Genome Biol. 7, R88 (2006).
46. Glusman, G., Yanai, I., Rubin, I. & Lancet, D. The complete human olfactory subgenome. Genome Res. 11, 685–702 (2001).
47. Zhang, X. H., Zhang, X. M. & Firestein, S. Comparative genomics of odorant and pheromone receptor genes in rodents. Genomics 89, 441–450 (2007).
48. DeMaria, S. & Ngai, J. The cell biology of smell. J. Cell Biol. 191, 443–452 (2010).
49. Mombaerts, P. Genes and ligands for odorant, vomeronasal and taste receptors. Nat. Rev. Neurosci. 5, 263–278 (2004).
50. Olender, T. et al. The human olfactory transcriptome. BMC Genomics 17, 619 (2016).
51. Zhang, X. & Firestein, S. The olfactory receptor gene superfamily of the mouse. Nat. Neurosci. 5, 124–133 (2002).
52. Kanageswaran, N. et al. Deep sequencing of the murine olfactory receptor neuron transcriptome. PLOS ONE 10, e0113170 (2015).
53. Niimura, Y., Matsui, A. & Touhara, K. Extreme expansion of the olfactory receptor gene repertoire in African elephants and evolutionary dynamics of orthologous gene groups in 13 placental mammals. Genome Res. 24, 1485–1496 (2014).
54. Gilad, Y., Man, O. & Glusman, G. A comparison of the human and chimpanzee olfactory receptor gene repertoires. Genome Res. 15, 224–230 (2005).
55. Reed, R. R. After the holy grail: establishing a molecular basis for mammalian olfaction. Cell 116, 329–336 (2004).
56. Hayden, S. & Teeling, E. C. The molecular biology of vertebrate olfaction. Anat. Rec. 297, 2216–2226 (2014).
57. Hasin, Y. et al. High-resolution copy-number variation map reflects human olfactory receptor diversity and evolution. PLOS Genet. 4, e1000249 (2008).
58. Menashe, I. et al. Genetic elucidation of human hyperosmia to isovaleric acid. PLOS Biol. 5, e284 (2007).
59. Niimura, Y. & Nei, M. Evolution of olfactory receptor genes in the human genome. Proc. Natl Acad. Sci. USA 100, 12235–12240 (2003).
60. Sosinsky, A., Glusman, G. & Lancet, D. The genomic structure of human olfactory receptor genes. Genomics 70, 49–61 (2000).
61. Saito, H., Kubota, M., Roberts, R. W., Chi, Q. Y. & Matsunami, H. RTP family members induce functional expression of mammalian odorant receptors. Cell 119, 679–691 (2004).
62. Zhuang, H. & Matsunami, H. Synergism of accessory factors in functional expression of mammalian odorant receptors. J. Biol. Chem. 282, 15284–15293 (2007).
63. Sharma, R. et al. Olfactory receptor accessory proteins play crucial roles in receptor function and gene choice. eLife 6, e21895 (2017).
64. Neuhaus, E. M., Mashukova, A., Zhang, W., Barbour, J. & Hatt, H. A specific heat shock protein enhances the expression of mammalian olfactory receptor proteins. Chem. Senses 31, 445–452 (2006).
65. Malnic, B., Hirono, J., Sato, T. & Buck, L. B. Combinatorial receptor codes for odors. Cell 96, 713–723 (1999).
66. Buck, L. B. The molecular architecture of odor and pheromone sensing in mammals. Cell 100, 611–618 (2000).
67. Ache, B. W. Odorant-specific modes of signaling in mammalian olfaction. Chem. Senses 35, 533–539 (2010).
68. Chess, A., Simon, I., Cedar, H. & Axel, R. Allelic inactivation regulates olfactory receptor gene expression. Cell 78, 823–834 (1994).
69. Clowney, E. J. et al. High-throughput mapping of the promoters of the mouse olfactory receptor genes reveals a new type of mammalian promoter and provides insight into olfactory receptor gene regulation. Genome Res. 21, 1249–1259 (2011).
70. Ebrahimi, F. A. & Chess, A. Olfactory neurons are interdependent in maintaining axonal projections. Curr. Biol. 10, 219–222 (2000).
71. Serizawa, S. et al. Negative feedback regulation ensures the one receptor-one olfactory neuron rule in mouse. Science 302, 2088–2094 (2003).
72. Shykind, B. M. et al. Gene switching and the stability of odorant receptor gene choice. Cell 117, 801–815 (2004).
73. Vassalli, A., Rothman, A., Feinstein, P., Zapotocky, M. & Mombaerts, P. Minigenes impart odorant receptor-specific axon guidance in the olfactory bulb. Neuron 35, 681–696 (2002).
74. Degl’Innocenti, A. & D’Errico, A. Regulatory features for odorant receptor genes in the mouse genome. Front. Genet. 8, 19 (2017).
75. Don, C. G. & Riniker, S. Scents and sense: in silico perspectives on olfactory receptors. J. Comput. Chem. 35, 2279–2287 (2014).
76. Persuy, M. A. et al. Mammalian olfactory receptors: molecular mechanisms of odorant detection, 3D-modeling, and structure-activity relationships. Prog. Mol. Biol. Transl Sci. 130, 1–36 (2015).
77. Rossetti, G., Dibenedetto, D., Calandrini, V., Giorgetti, A. & Carloni, P. Structural predictions of neurobiologically relevant G-protein coupled receptors and intrinsically disordered proteins. Arch. Biochem. Biophys. 582, 91–100 (2015).
78. Launay, G., Sanz, G., Pajot-Augy, E. & Gibrat, J. F. Modeling of mammalian olfactory receptors and docking of odorants. Biophys. Rev. 4, 255–269 (2012).
79. Xiang, Z. Advances in homology protein structure modeling. Curr. Protein Pept. Sci. 7, 217–227 (2006).
80. Gelis, L., Wolf, S., Hatt, H., Neuhaus, E. M. & Gerwert, K. Prediction of a ligand-binding niche within a human olfactory receptor by combining site-directed mutagenesis with dynamic homology modeling. Angew. Chem. Int. Ed. Engl. 51, 1274–1278 (2012).
81. Abaffy, T., Malhotra, A. & Luetje, C. W. The molecular basis for ligand specificity in a mouse olfactory receptor: a network of functionally important residues. J. Biol. Chem. 282, 1216–1224 (2007).
82. Bavan, S., Sherman, B., Luetje, C. W. & Abaffy, T. Discovery of novel ligands for mouse olfactory receptor MOR42-3 using an in silico screening approach and in vitro validation. PLOS ONE 9, e92064 (2014).
83. Wolf, S., Gelis, L., Dorrich, S., Hatt, H. & Kraft, P. Evidence for a shape-based recognition of odorants in vivo in the human nose from an analysis of the molecular mechanism of lily-of-the-valley odorants detection in the Lilial and Bourgeonal family using the C/Si/Ge/Sn switch strategy. PLOS ONE 12, e0182147 (2017).
84. Behrens, M. et al. Structure-function relationships of olfactory and taste receptors. Chem. Senses 43, 81–87 (2018).
85. Ho, J. et al. Molecular recognition of ketamine by a subset of olfactory G protein-coupled receptors. Sci. Signal. 8, ra33 (2015).
86. Thach, T. T., Hong, Y. J., Lee, S. & Lee, S. J. Molecular determinants of the olfactory receptor Olfr544 activation by azelaic acid. Biochem. Biophys. Res. Commun. 485, 241–248 (2017).
87. Wolf, S. et al. Dynamical binding modes determine agonistic and antagonistic ligand effects in the prostate-specific G-protein coupled receptor (PSGR). Sci. Rep. 7, 16007 (2017).
88. Kleene, S. J. The electrochemical basis of odor transduction in vertebrate olfactory cilia. Chem. Senses 33, 839–859 (2008).
89. Schild, D. & Restrepo, D. Transduction mechanisms in vertebrate olfactory receptor cells. Physiol. Rev. 78, 429–466 (1998).
90. Jones, D. T. & Reed, R. R. Golf: an olfactory neuron specific-G protein involved in odorant signal transduction. Science 244, (790–795 (1989).
91. Firestein, S. How the olfactory system makes sense of scents. Nature 413, 211–218 (2001). This is a basic summary of the olfactory system, covering topics ranging from the relevant molecules to perception.
92. − channels in olfactory transduction. Channels (Austin) 11, 399–414 (2017).
93. − channel TMEM16B regulates action potential firing and axonal targeting in olfactory sensory neurons. J. Gen. Physiol. 148, 293–311 (2016).
94. Rasche, S. et al. TMEM16B is specifically expressed in the cilia of olfactory sensory neurons. Chem. Senses 35, 239–245 (2010).
95. Adler, E. et al. A novel family of mammalian taste receptors. Cell 100, 693–702 (2000).
96. Chandrashekar, J. et al. T2Rs function as bitter taste receptors. Cell 100, 703–711 (2000).
97. Roper, S. D. & Chaudhari, N. Taste buds: cells, signals and synapses. Nat. Rev. Neurosci. 18, 485–497 (2017).
98. Nelson, G. et al. An amino-acid taste receptor. Nature 416, 199–202 (2002).
99. Yasumatsu, K. et al. Involvement of multiple taste receptors in umami taste: analysis of gustatory nerve responses in metabotropic glutamate receptor 4 knockout mice. J. Physiol. 593, 1021–1034 (2015).
100. Wellendorph, P., Johansen, L. D. & Brauner-Osborne, H. Molecular pharmacology of promiscuous seven transmembrane receptors sensing organic nutrients. Mol. Pharmacol. 76, 453–465 (2009).
101. Meyerhof, W. et al. The molecular receptive ranges of human TAS2R bitter taste receptors. Chem. Senses 35, 157–170 (2010).
102. Laugerette, F. et al. CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretions. J. Clin. Invest. 115, 3177–3184 (2005).
103. Cornall, L. M. et al. GPR120 agonism as a countermeasure against metabolic diseases. Drug Discov. Today 19, 670–679 (2014).
104. Hara, T. et al. Free fatty acid receptors FFAR1 and GPR120 as novel therapeutic targets for metabolic disorders. J. Pharmaceut. Sci. 100, 3594–3601 (2011).
105. Mancini, A. D. & Poitout, V. GPR40 agonists for the treatment of type 2 diabetes: life after ‘TAKing’ a hit. Diabetes Obes. Metab. 17, 622–629 (2015).
106. Clapp, T. R. et al. Tonic activity of Galpha-gustducin regulates taste cell responsivity. FEBS Lett. 582, 3783–3787 (2008).
107. Taruno, A. et al. CALHM1 ion channel mediates purinergic neurotransmission of sweet, bitter and umami tastes. Nature 495, 223–226 (2013).
108. Ma, Z. et al. CALHM3 is essential for rapid ion channel-mediated purinergic neurotransmission of GPCR-mediated tastes. Neuron 98, 547–561 (2018).
109. Chen, X. K., Gabitto, M., Peng, Y. Q., Ryba, N. J. P. & Zuker, C. S. A gustotopic map of taste qualities in the mammalian brain. Science 333, 1262–1266 (2011).
110. Yarmolinsky, D. A., Zuker, C. S. & Ryba, N. J. P. Common sense about taste: from mammals to insects. Cell 139, 234–244 (2009).
111. Parmentier, M. et al. Expression of members of the putative olfactory receptor gene family in mammalian germ cells. Nature 355, 453–455 (1992). The study, which appeared soon after the discovery of OR genes in 1991, provides convincing evidence of extra-nasal expression of members of the OR gene family.
112. 2+ dynamics correlate with diverse behavioral phenotypes in human sperm. J. Biol. Chem. 286, 17311–17325 (2011).
113. Flegel, C. et al. Characterization of the olfactory receptors expressed in human spermatozoa. Front. Mol. Biosci. 2, 73 (2015).
114. Fukuda, N., Yomogida, K., Okabe, M. & Touhara, K. Functional characterization of a mouse testicular olfactory receptor and its role in chemosensing and in regulation of sperm motility. J. Cell Sci. 117, 5835–5845 (2004).
115. Choi, Y., Hur, C. G. & Park, T. Induction of olfaction and cancer-related genes in mice fed a high-fat diet as assessed through the mode-of-action by network identification analysis. PLOS ONE 8, e56610 (2013).
116. Ng, S. F. et al. Paternal high-fat diet consumption induces common changes in the transcriptomes of retroperitoneal adipose and pancreatic islet tissues in female rat offspring. FASEB J. 28, 1830–1841 (2014).
117. Aisenberg, W. H. et al. Defining an olfactory receptor function in airway smooth muscle cells. Sci. Rep. 6, 38231 (2016).
118. Kalbe, B. et al. Olfactory receptors modulate physiological processes in human airway smooth muscle cells. Front. Physiol. 10.3389/fphys.2016.00339 (2016).
119. Li, J. J. et al. Activation of olfactory receptors on mouse pulmonary macrophages promotes monocyte chemotactic protein-1 production. PLOS ONE 8, e80148 (2013).
120. Jovancevic, N. et al. Medium-chain fatty acids modulate myocardial function via a cardiac odorant receptor. Bas. Res. Cardiol. 112, 13 (2017). This is the first study to demonstrate the functional role of an OR in the human heart. In this study, in vitro and ex vivo experiments are used to reveal that OR51E1 activation by medium-chain fatty acids induces negative inotropic and chronotropic effects on the human myocardium.
121. Kalbe, B. et al. Olfactory signaling components and olfactory receptors are expressed in tubule cells of the human kidney. Arch. Biochem. Biophys. 610, 8–15 (2016).
122. Pluznick, J. L. et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc. Natl Acad. Sci. USA 110, 4410–4415 (2013). This study investigates renal expression of OLFR78 in terms of blood pressure regulation. In this study, activation of the receptor by short-chain fatty acids (optimally propionate) is shown to induce renin secretion and to regulate blood pressure in mice. The functionality of the receptor is also demonstrated in knockout mice.
123. Pluznick, J. L. et al. Functional expression of the olfactory signaling system in the kidney. Proc. Natl Acad. Sci. USA 106, 2059–2064 (2009).
124. Shepard, B. D. et al. A renal olfactory receptor aids in kidney glucose handling. Sci. Rep. 6, 35215 (2016).
125. Massberg, D. et al. Monoterpene (-)-citronellal affects hepatocarcinoma cell signaling via an olfactory receptor. Arch. Biochem. Biophys. 566, 100–109 (2015).
126. Tong, T. et al. Olfactory receptor 10J5 responding to alpha-cedrene regulates hepatic steatosis via the cAMP-PKA pathway. Sci. Rep. 7, 9471 (2017).
127. Wu, C. et al. Activation of OR1A1 suppresses PPAR-gamma expression by inducing HES-1 in cultured hepatocytes. Int. J. Biochem. Cell Biol. 64, 75–80 (2015).
128. Gu, X. L. et al. Chemosensory functions for pulmonary neuroendocrine cells. Am. J. Respir. Cell. Mol. Biol. 50, 637–646 (2014).
129. Giandomenico, V. et al. Olfactory receptor 51E1 as a novel target for diagnosis in somatostatin receptor-negative lung carcinoids. J. Mol. Endocrinol. 51, 277–286 (2013).
130. Rodriguez, M. et al. PSGR promotes prostatic intraepithelial neoplasia and prostate cancer xenograft growth through NF-kappa B. Oncogenesis 3, e114 (2014).
131. Abaffy, T. et al. A Testosterone metabolite 19-hydroxyandrostenedione induces neuroendocrine trans-differentiation of prostate cancer cells via an ectopic olfactory receptor. Front. Oncol. 8, 162 (2018).
132. Weber, M., Pehl, U., Breer, H. & Strotmann, J. Olfactory receptor expressed in ganglia of the autonomic nervous system. J. Neurosci. Res. 68, 176–184 (2002).
133. Manteniotis, S. et al. Deorphanization and characterization of the ectopically expressed olfactory receptor OR51B5 in myelogenous leukemia cells. Cell Death Discov. 2, 16010 (2016).
134. Garcia-Esparcia, P. et al. Functional genomics reveals dysregulation of cortical olfactory receptors in Parkinson disease: novel putative chemoreceptors in the human brain. J. Neuropathol. Exp. Neurol. 72, 524–539 (2013).
135. Zhao, W. et al. Decreased level of olfactory receptors in blood cells following traumatic brain injury and potential association with tauopathy. J. Alzheimers Dis. 34, 417–429 (2013).
136. Grison, A. et al. Mesencephalic dopaminergic neurons express a repertoire of olfactory receptors and respond to odorant-like molecules. BMC Genomics 15, 729 (2014).
137. Gaudel, F. et al. Expression of the cerebral olfactory receptors Olfr110/111 and Olfr544 is altered during aging and in Alzheimer’s disease-like mice. Mol. Neurobiol. 10.1007/s12035-018-1196-4 (2018).
138. Ferrer, I. et al. Olfactory receptors in non-chemosensory organs: the nervous system in health and disease. Front. Aging Neurosci. 8, 163 (2016).
139. Ansoleaga, B. et al. Dysregulation of brain olfactory and taste receptors in AD, PSP and CJD, and AD-related model. Neuroscience 248, 369–382 (2013).
140. Kaji, I., Karaki, S. & Kuwahara, A. Effects of luminal thymol on epithelial transport in human and rat colon. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G1132–G1143 (2011).
141. Morita, R. et al. Olfactory receptor family 7 subfamily C member 1 is a novel marker of colon cancer-initiating cells and is a potent target of immunotherapy. Clin. Cancer Res. 22, 3298–3309 (2016).
142. Xu, L. et al. Genome-wide association study identifies common genetic variants associated with salivary gland carcinoma and its subtypes. Cancer 121, 2367–2374 (2015).
143. Braun, T., Voland, P., Kunz, L., Prinz, C. & Gratzl, M. Enterochromaffin cells of the human gut: sensors for spices and odorants. Gastroenterology 132, 1890–1901 (2007). This is the first study to show that ORs are functionally expressed in the human intestine and that activation thereof by odorants triggers calcium-induced serotonin release, stimulating gut motility and secretion.
144. Kidd, M. et al. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G260–G272 (2008).
145. Primeaux, S. D., Braymer, H. D. & Bray, G. A. High fat diet differentially regulates the expression of olfactory receptors in the duodenum of obesity-prone and obesity-resistant rats. Dig. Dis. Sci. 58, 72–76 (2013).
146. Kalbe, B. et al. OR2H2 regulates the differentiation of human myoblast cells by its ligand aldehyde 13–13. Arch. Biochem. Biophys. 645, 72–80 (2018).
147. Kang, N. et al. Olfactory receptor Olfr544 responding to azelaic acid regulates glucagon secretion in alpha-cells of mouse pancreatic islets. Biochem. Biophys. Res. Commun. 460, 616–621 (2015).
148. 2+ decrease and serotonin secretion of QGP-1 cells via a PKG-mediated pathway. J. Mol. Endocrinol. 57, 201–210 (2016).
149. Itakura, S., Ohno, K., Ueki, T., Sato, K. & Kanayama, N. Expression of Golf in the rat placenta: possible implication in olfactory receptor transduction. Placenta 27, 103–108 (2006).
150. Jovancevic, N. et al. Odorant receptor 51E2 agonist beta-ionone regulates RPE cell migration and proliferation. Front. Physiol. 8, 888 (2017).
151. Jovancevic, N. et al. Deep sequencing of the human retinae reveals the expression of odorant receptors. Front. Cell. Neurosci. 11, 03 (2017).
152. Gaudin, J. C., Breuils, L. & Haertlé, T. New GPCRs from a human lingual cDNA library. Chem. Senses 26, 1157–1166 (2001).
153. Durzyn´ski, L. et al. Olfactory-like receptor cDNAs are present in human lingual cDNA libraries. Biochem. Biophys. Res. Commun. 333, 264–272 (2005).
154. Dreyer, W. J. The area code hypothesis revisited: olfactory receptors and other related transmembrane receptors may function as the last digits in a cell surface code for assembling embryos. Proc. Natl Acad. Sci. USA 95, 9072–9077 (1998).
155. Hanchate, N. K. et al. Single-cell transcriptomics reveals receptor transformations during olfactory neurogenesis. Science 350, 1251–1255 (2015).
156. Zhang, X. et al. High-throughput microarray detection of olfactory receptor gene expression in the mouse. Proc. Natl Acad. Sci. USA 101, 14168–14173 (2004).
157. Flegel, C. et al. RNA-seq analysis of human trigeminal and dorsal root ganglia with a focus on chemoreceptors. PLOS ONE 10, e0128951 (2015).
158. Weyand, I. et al. Cloning and functional expression of a cyclic-nucleotide-gated channel from mammalian sperm. Nature 368, 859–863 (1994).
159. Singh, A. P. & Rajender, S. CatSper channel, sperm function and male fertility. Reprod. Biomed. Online 30, 28–38 (2015).
160. Spehr, J. et al. G protein-coupled receptor signaling via Src kinase induces endogenous human transient receptor potential vanilloid type 6 (TRPV6) channel activation. J. Biol. Chem. 286, 13184–13192 (2011).
161. Wiese, H. et al. Quantitative phosphoproteomics reveals the protein tyrosine kinase Pyk2 as a central effector of olfactory receptor signaling in prostate cancer cells. Biochim. Biophys. Acta 1854, 632–640 (2015).
162. Goff, S. A. & Klee, H. J. Plant volatile compounds: sensory cues for health and nutritional value? Science 311, 815–819 (2006).
163. 2+ imaging. ChemPlusChem 78, 695–702 (2013).
164. Sinding, C., Kemper, E., Spornraft-Ragaller, P. & Hummel, T. Decreased perception of bourgeonal may be linked to male idiopathic infertility. Chem. Senses 38, 439–445 (2013).
165. Ottaviano, G. et al. Human olfactory sensitivity for bourgeonal and male infertility: a preliminary investigation. Eur. Arch. Otorhinolaryngol. 270, 3079–3086 (2013).
166. Neuhaus, E. M., Mashukova, A., Barbour, J., Wolters, D. & Hatt, H. Novel function of beta-arrestin2 in the nucleus of mature spermatozoa. J. Cell Sci. 119, 3047–3056 (2006).
167. Spehr, M. et al. Particulate adenylate cyclase plays a key role in human sperm olfactory receptor-mediated chemotaxis. J. Biol. Chem. 279, 40194–40203 (2004).
168. Vosshall, L. B. Olfaction: attracting both sperm and the nose. Curr. Biol. 14, R918–R920 (2004).
169. Canfora, E. E., Jocken, J. W. & Blaak, E. E. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat. Rev. Endocrinol. 11, 577–591 (2015).
170. Zhou, T., Chien, M. S., Kaleem, S. & Matsunami, H. Single cell transcriptome analysis of mouse carotid body glomus cells. J. Physiol. 594, 4225–4251 (2016).
171. Chang, A. J., Ortega, F. E., Riegler, J., Adison, D. V. M. & Krasnow, M. A. Oxygen regulation of breathing through an olfactory receptor activated by lactate. Nature 527, 240–244 (2015).
172. Pluznick, J. L. Microbial short-chain fatty acids and blood pressure regulation. Curr. Hypertens. Rep. 19, 25 (2017).
173. Pichavant, C., Burkholder, T. J. & Pavlath, G. K. Decrease of myofiber branching via muscle-specific expression of the olfactory receptor mOR23 in dystrophic muscle leads to protection against mechanical stress. Skelet. Muscle 6, 2 (2016).
174. Kim, K. S. et al. Activation of intestinal olfactory receptor stimulates glucagon-like peptide-1 secretion in enteroendocrine cells and attenuates hyperglycemia in type 2 diabetic mice. Sci. Rep. 7, 13978 (2017).
175. Julia, V., Macia, L. & Dombrowicz, D. The impact of diet on asthma and allergic diseases. Nat. Rev. Immunol. 15, 308–322 (2015).
176. An, S. S. & Liggett, S. B. Taste and smell GPCRs in the lung: evidence for a previously unrecognized widespread chemosensory system. Cell Signal. 41, 82–88 (2018).
177. Jarick, I. et al. Novel common copy number variation for early onset extreme obesity on chromosome 11q11 identified by a genome-wide analysis. Hum. Mol. Genet. 20, 840–852 (2011).
178. Choquette, A. C. et al. Association between olfactory receptor genes, eating behavior traits and adiposity: results from the Quebec Family Study. Physiol. Behav. 105, 772–776 (2012).
179. Knijnenburg, J. et al. Postzygotic telomere capture causes segmental UPD, duplication and deletion of chromosome 8p in a patient with intellectual disability and obesity. Eur. J. Med. Genet. 60, 445–450 (2017).
180. Mariman, E. C. M. et al. Olfactory receptor genes cooperate with protocadherin genes in human extreme obesity. Genes Nutr. 10, 465 (2015).
181. Lunde, K. et al. Genetic variation of an odorant receptor OR7D4 and sensory perception of cooked meat containing androstenone. PLOS ONE 7, e35259 (2012).
182. Sondersorg, A. C. et al. Chemosensory information processing between keratinocytes and trigeminal neurons. J. Biol. Chem. 289, 17529–17540 (2014).
183. Wojcik, S. et al. Functional characterization of the extranasal OR2A4/7 expressed in human melanocytes. Exp. Dermatol. 10.1111/exd.13764 (2018).
184. Ichimura, A., Hasegawa, S., Kasubuchi, M. & Kimura, I. Free fatty acid receptors as therapeutic targets for the treatment of diabetes. Front. Pharmacol. 5, 236 (2014).
185. Pezeshkian, M. & Mahtabipour, M. R. Epicardial and subcutaneous adipose tissue fatty acids profiles in diabetic and non-diabetic patients candidate for coronary artery bypass graft. Bioimpacts 3, 83–89 (2013).
186. Cui, T. et al. Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas. Eur. J. Endocrinol. 168, 253–261 (2013).
187. Rodriguez, M. et al. Prostate-specific G-protein-coupled receptor collaborates with loss of PTEN to promote prostate cancer progression. Oncogene 35, 1153–1162 (2016).
188. Duncan, R. E., Lau, D., El-Sohemy, A. & Archer, M. C. Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity. Biochem. Pharmacol. 68, 1739–1747 (2004).
189. Liu, J.-R. et al. β-Ionone suppresses mammary carcinogenesis, proliferative activity and induces apoptosis in the mammary gland of the Sprague-Dawley rat. Int. J. Cancer 122, 2689–2698 (2008).
190. Mo, H. & Elson, C. E. Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J. Nutr. 129, 804–813 (1999).
191. Elson, C. E., Peffley, D. M., Hentosh, P. & Mo, H. Isoprenoid-mediated inhibition of mevalonate synthesis: potential application to cancer. Proc. Soc. Exp. Biol. Med. 221, 294–311 (1999).
192. Gelis, L. et al. Functional expression of olfactory receptors in human primary melanoma and melanoma metastasis. Exp. Dermatol. 26, 569–576 (2017).
193. Matsueda, S. et al. Identification of prostate-specific G-protein coupled receptor as a tumor antigen recognized by CD8(+) T cells for cancer immunotherapy. PLOS ONE 7, e45756 (2012).
194. Huang, M. et al. Terpenoids: natural products for cancer therapy. Expert. Opin. Investig. Drugs 21, 1801–1818 (2012).
195. Gould, M. N. Cancer chemoprevention and therapy by monoterpenes. Env. Health Persp. 105 (Suppl. 4), 977–979 (1997).
196. O’Hayre, M., Degese, M. S. & Gutkind, J. S. Novel insights into G protein and G protein-coupled receptor signaling in cancer. Curr. Opin. Cell Biol. 27, 126–135 (2014).
197. Lappano, R. & Maggiolini, M. GPCRs and cancer. Acta Pharmacol. Sin. 33, 351–362 (2012).
198. Hofer, D., Puschel, B. & Drenckhahn, D. Taste receptor-like cells in the rat gut identified by expression of alpha-gustducin. Proc. Natl Acad. Sci. USA 93, 6631–6634 (1996).
199. Wu, S. V. et al. Expression of bitter taste receptors of the T2R family in the gastrointestinal tract and enteroendocrine STC-1 cells. Proc. Natl Acad. Sci. USA 99, 2392–2397 (2002).
200. Quesada-Lopez, T. et al. The lipid sensor GPR120 promotes brown fat activation and FGF21 release from adipocytes. Nat. Commun. 7, 13479 (2016). This is the first study to show that FFAR4 controls the thermogenic activity of brown adipose tissue and promotes browning of white adipose tissue via a process involving FGF21.
201. Oh, D. Y. et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687–698 (2010).
202. Oh, D. Y. et al. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat. Med. 20, 942–947 (2014).
203. Ichimura, A. et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483, 350–354 (2012).
204. Masubuchi, Y. et al. A novel regulatory function of sweet taste-sensing receptor in adipogenic differentiation of 3T3-L1 cells. PLOS ONE 8, e54500 (2013).
205. Simon, B. R. et al. Sweet taste receptor deficient mice have decreased adiposity and increased bone mass. PLOS ONE 9, e86454 (2014).
206. Avau, B. & Depoortere, I. The bitter truth about bitter taste receptors: beyond sensing bitter in the oral cavity. Acta Physiol. 216, 407–420 (2016).
207. 2+ concentration and the ciliary beat frequency, thus eliminating offending compounds.
208. Gulbransen, B. D., Clapp, T. R., Finger, T. E. & Kinnamon, S. C. Nasal solitary chemoreceptor cell responses to bitter and trigeminal stimulants in vitro. J. Neurophysiol. 99, 2929–2937 (2008).
209. Tizzano, M. et al. Nasal chemosensory cells use bitter taste signaling to detect irritants and bacterial signals. Proc. Natl Acad. Sci. USA 107, 3210–3215 (2010).
210. Krasteva, G. et al. Cholinergic chemosensory cells in the trachea regulate breathing. Proc. Natl Acad. Sci. USA 108, 9478–9483 (2011).
211. Krasteva, G., Canning, B. J., Papadakis, T. & Kummer, W. Cholinergic brush cells in the trachea mediate respiratory responses to quorum sensing molecules. Life Sci. 91, 992–996 (2012).
212. Lee, R. J. et al. Bacterial D-amino acids suppress sinonasal innate immunity through sweet taste receptors in solitary chemosensory cells. Sci. Sig. 10, eaam7703 (2017).
213. Hariri, B. M. et al. Flavones modulate respiratory epithelial innate immunity: anti-inflammatory effects and activation of the T2R14 receptor. J. Biol. Chem. 292, 8484–8497 (2017).
214. Lund, T. C. et al. Bone marrow stromal and vascular smooth muscle cells have chemosensory capacity via bitter taste receptor expression. PLOS ONE 8, e58945 (2013).
215. Ren, X., Zhou, L., Terwilliger, R., Newton, S. S. & de Araujo, I. E. Sweet taste signaling functions as a hypothalamic glucose sensor. Front. Integr. Neurosci. 3, 12 (2009).
216. Martin, B. et al. Altered learning, memory, and social behavior in type 1 taste receptor subunit 3 knock-out mice are associated with neuronal dysfunction. J. Biol. Chem. 292, 11508–11530 (2017).
217. Singh, N., Chakraborty, R., Bhullar, R. P. & Chelikani, P. Differential expression of bitter taste receptors in non-cancerous breast epithelial and breast cancer cells. Biochem. Biophys. Res. Commun. 446, 499–503 (2014).
218. Foster, S. R. et al. Expression, regulation and putative nutrient-sensing function of taste GPCRs in the heart. PLOS ONE 8, e64579 (2013).
219. Foster, S. R. et al. Bitter taste receptor agonists elicit G-protein-dependent negative inotropy in the murine heart. FASEB J. 28, 4497–4508 (2014).
220. Eclov, J. A. et al. EPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4. J. Lipid Res. 56, 2297–2308 (2015).
221. Malki, A. et al. Class I odorant receptors, TAS1R and TAS2R taste receptors, are markers for subpopulations of circulating leukocytes. J. Leukoc. Biol. 97, 533–545 (2015).
222. Orsmark-Pietras, C. et al. Transcriptome analysis reveals upregulation of bitter taste receptors in severe asthmatics. Eur. Respir. J. 42, 65–78 (2013).
223. Ekoff, M. et al. Bitter taste receptor (TAS2R) agonists inhibit IgE-dependent mast cell activation. J. Allergy Clin. Immunol. 134, 475–478 (2014).
224. Alvarez-Curto, E. & Milligan, G. Metabolism meets immunity: the role of free fatty acid receptors in the immune system. Biochem. Pharmacol. 114, 3–13 (2016).
225. Liu, X., Gu, F., Jiang, L., Chen, F. & Li, F. Expression of bitter taste receptor TAS2R105 in mouse kidney. Biochem. Biophys. Res. Commun. 458, 733–738 (2015).
226. Stone, V. M. et al. GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans. Diabetologia 57, 1182–1191 (2014).
227. Kyriazis, G. A., Soundarapandian, M. M. & Tyrberg, B. Sweet taste receptor signaling in beta cells mediates fructose-induced potentiation of glucose-stimulated insulin secretion. Proc. Natl Acad. Sci. USA 109, E524–E532 (2012).
228. Itoh, Y. et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422, 173–176 (2003).
229. Steneberg, P., Rubins, N., Bartoov-Shifman, R., Walker, M. D. & Edlund, H. The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse. Cell Metab. 1, 245–258 (2005).
230. Wolfle, U. et al. Expression and functional activity of the bitter taste receptors TAS2R1 and TAS2R38 in human keratinocytes. Skin Pharmacol. Physiol. 28, 137–146 (2015).
231. Arantes, E. L. et al. Topical docosahexaenoic acid (DHA) accelerates skin wound healing in rats and activates GPR120. Biol. Res. Nurs. 18, 411–419 (2016).
232. Mosinger, B. et al. Genetic loss or pharmacological blockade of testes-expressed taste genes causes male sterility. Proc. Natl Acad. Sci. USA 110, 12319–12324 (2013).
233. Li, F. & Zhou, M. Depletion of bitter taste transduction leads to massive spermatid loss in transgenic mice. Mol. Hum. Reprod. 18, 289–297 (2012).
234. Xu, J., Cao, J., Iguchi, N., Riethmacher, D. & Huang, L. Functional characterization of bitter-taste receptors expressed in mammalian testis. Mol. Hum. Reprod. 19, 17–28 (2013).
235. Clark, A. A. et al. TAS2R bitter taste receptors regulate thyroid function. FASEB J. 29, 164–172 (2015).
236. Deckmann, K. et al. Bitter triggers acetylcholine release from polymodal urethral chemosensory cells and bladder reflexes. Proc. Natl Acad. Sci. USA 111, 8287–8292 (2014).
237. Elliott, R. A., Kapoor, S. & Tincello, D. G. Expression and distribution of the sweet taste receptor isoforms T1R2 and T1R3 in human and rat bladders. J. Urol. 186, 2455–2462 (2011).
238. Saunders, C. J., Christensen, M., Finger, T. E. & Tizzano, M. Cholinergic neurotransmission links solitary chemosensory cells to nasal inflammation. Proc. Natl Acad. Sci. USA 111, 6075–6080 (2014).
239. Jeon, T. I., Seo, Y. K. & Osborne, T. F. Gut bitter taste receptor signalling induces ABCB1 through a mechanism involving CCK. Biochem. J. 438, 33–37 (2011).
240. 2+ channels. Am. J. Physiol. Cell Physiol. 291, C726–C739 (2006).
241. Jang, H. J. et al. Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc. Natl Acad. Sci. USA 104, 15069–15074 (2007).
242. Steensels, S., Vancleef, L. & Depoortere, I. The sweetener-sensing mechanisms of the ghrelin cell. Nutrients 8, E795 (2016).
243. Gribble, F. M. et al. Gut hormone regulation and secretion via FFA1 and FFA4. Handb. Exp. Pharmacol. 236, 181–203 (2017).
244. Miyamoto, J. et al. Nutritional signaling via free fatty acid receptors. Int. J. Mol. Sci. 17, 450 (2016).
245. Neiers, F., Canivenc-Lavier, M. C. & Briand, L. What does diabetes “taste” like? Curr. Diabetes Rep. 16, 49 (2016).
246. Reimann, F., Tolhurst, G. & Gribble, F. M. G-Protein-coupled receptors in intestinal chemosensation. Cell Metab. 15, 421–431 (2012).
247. Vancleef, L. et al. Obesity impairs oligopeptide/amino acid-induced ghrelin release and smooth muscle contractions in the human proximal stomach. Mol. Nutr. Food Res. 62, 1700804 (2018).
248. Janssen, S., Laermans, J., Iwakura, H., Tack, J. & Depoortere, I. Sensing of fatty acids for octanoylation of ghrelin involves a gustatory G-protein. PLOS ONE 7, e40168 (2012).
249. Engelstoft, M. S. et al. Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells. Mol. Metab. 2, 376–392 (2013).
250. Vancleef, L. et al. Chemosensory signalling pathways involved in sensing of amino acids by the ghrelin cell. Sci. Rep. 5, 15725 (2015).
251. Haid, D. C., Jordan-Biegger, C., Widmayer, P. & Breer, H. Receptors responsive to protein breakdown products in g-cells and d-cells of mouse, swine and human. Front. Physiol. 3, 65 (2012).
252. Feng, J. et al. Calcium-sensing receptor is a physiologic multimodal chemosensor regulating gastric G-cell growth and gastrin secretion. Proc. Natl Acad. Sci. USA 107, 17791–17796 (2010).
253. Janssen, S. et al. Bitter taste receptors and alpha-gustducin regulate the secretion of ghrelin with functional effects on food intake and gastric emptying. Proc. Natl Acad. Sci. USA 108, 2094–2099 (2011).
254. Liszt, K. I. et al. Caffeine induces gastric acid secretion via bitter taste signaling in gastric parietal cells. Proc. Natl Acad. Sci. USA 114, E6260–E6269 (2017).
255. Avau, B. et al. Targeting extra-oral bitter taste receptors modulates gastrointestinal motility with effects on satiation. Sci. Rep. 5, 15985 (2015). This is the first study to show that functional bitter taste receptors are expressed on smooth muscle cells and that intragastric administration of bitter materials to humans impairs relaxation of the proximal stomach, with flow-on effects on satiation.
256. Daly, K. et al. Sensing of amino acids by the gut-expressed taste receptor T1R1-T1R3 stimulates CCK secretion. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G271–G282 (2013).
257. Liou, A. P. et al. The extracellular calcium-sensing receptor is required for cholecystokinin secretion in response to L-phenylalanine in acutely isolated intestinal I cells. Am. J. Physiol. Gastrointest. Liver Physiol. 300, G538–G546 (2011).
258. Liou, A. P. et al. The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin. Gastroenterology 140, 903–912 (2011).
259. Edfalk, S., Steneberg, P. & Edlund, H. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes 57, 2280–2287 (2008).
260. Tanaka, T. et al. Free fatty acids induce cholecystokinin secretion through GPR120. Naunyn Schmiedebergs Arch. Pharmacol. 377, 523–527 (2008).
261. Deloose, E., Corsetti, M., Van Oudenhove, L., Depoortere, I. & Tack, J. Intragastric infusion of the bitter tastant quinine suppresses hormone release and antral motility during the fasting state in healthy female volunteers. Neurogastroenterol. Motil. 30, e13171 (2018).
262. Deloose, E. et al. Intragastric infusion of denatonium benzoate attenuates interdigestive gastric motility and hunger scores in healthy female volunteers. Am. J. Clin. Nutr. 105, 580–588 (2017).
263. Iven, J. et al. Intragastric quinine administration decreases hedonic eating in healthy women through peptide-mediated gut-brain signaling mechanisms. Nutr. Neurosci. 2, 1–13 (2018).
264. Heck, C. I. & de Mejia, E. G. Yerba Mate Tea (Ilex paraguariensis): a comprehensive review on chemistry, health implications, and technological considerations. J. Food Sci. 72, R138–R151 (2007).
265. Swanston-Flatt, S. K., Day, C., Flatt, P. R., Gould, B. J. & Bailey, C. J. Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res. 10, 69–73 (1989).
266. Yu, Y. et al. Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways. Biochem. Pharmacol. 97, 173–177 (2015).
267. Le Neve, B., Foltz, M., Daniel, H. & Gouka, R. The steroid glycoside H.g.-12 from Hoodia gordonii activates the human bitter receptor TAS2R14 and induces CCK release from HuTu-80 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G1368–G1375 (2010).
268. Huang, T. N., Lu, K. N., Pai, Y. P., Chin, H. & Huang, C. J. Role of GLP-1 in the hypoglycemic effects of wild bitter gourd. Evid. Based Complement. Alternat. Med. 2013, 625892 (2013).
269. Zhang, Z. et al. Berberine activates thermogenesis in white and brown adipose tissue. Nat. Commun. 5, 5493 (2014).
270. van Heerden, F. R. et al. An appetite suppressant from Hoodia species. Phytochemistry 68, 2545–2553 (2007).
271. Alam, M. A. et al. Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome. J. Lipids 2015, 496169 (2015).
272. Andersen, T. & Fogh, J. Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients. J. Hum. Nutr. Diet 14, 243–250 (2001).
273. Hussein, G. M. et al. Protective and ameliorative effects of mate (Ilex paraguariensis) on metabolic syndrome in TSOD mice. Phytomedicine 19, 88–97 (2011).
274. Kang, Y. R. et al. Anti-obesity and anti-diabetic effects of Yerba Mate (Ilex paraguariensis) in C57BL/6 J mice fed a high-fat diet. Lab Anim. Res. 28, 23–29 (2012).
275. Kok, B. P. et al. Intestinal bitter taste receptor activation alters hormone secretion and imparts metabolic benefits. Mol. Metab. 10.1016/j.molmet.2018.07.013 (2018).
276. Kern, P. A. et al. Effects of KDT501 on metabolic parameters in insulin-resistant prediabetic humans. J. Endocr. Soc. 1, 650–659 (2017).
277. Fleckenstein-Elsen, M. et al. Eicosapentaenoic acid and arachidonic acid differentially regulate adipogenesis, acquisition of a brite phenotype and mitochondrial function in primary human adipocytes. Mol. Nutr. Food Res. 60, 2065–2075 (2016).
278. Abbott, K. A., Burrows, T. L., Thota, R. N., Acharya, S. & Garg, M. L. Do omega-3 PUFAs affect insulin resistance in a sex-specific manner? A systematic review and meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 104, 1470–1484 (2016).
279. He, X. X. et al. Effectiveness of omega-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. PLOS ONE 11, e0162368 (2016).
280. Marcinak, J. et al. Fasiglifam for glycaemic control in people with type 2 diabetes: a phase III, placebo-controlled study. Diabetes Obes. Metab. 19, 1714–1721 (2017).
281. Lee, R. J., Chen, B., Redding, K. M., Margolskee, R. F. & Cohen, N. A. Mouse nasal epithelial innate immune responses to Pseudomonas aeruginosa quorum-sensing molecules require taste signaling components. Innate Immun. 20, 606–617 (2014).
282. Finger, T. E. et al. Solitary chemoreceptor cells in the nasal cavity serve as sentinels of respiration. Proc. Natl Acad. Sci. USA 100, 8981–8986 (2003).
283. Sharma, P. et al. Bitter taste receptor agonists mitigate features of allergic asthma in mice. Sci. Rep. 7, 46166 (2017).
284. Milligan, G. et al. FFA4/GPR120: pharmacology and therapeutic opportunities. Trends Pharmacol. Sci. 38, 809–821 (2017).
285. Jager, W., Buchbauer, G., Jirovetz, L. & Fritzer, M. Percutaneous-absorption of lavender oil from a massage oil. J. Soc. Cosmet. Chem. 43, 49–54 (1992).
286. Nuemket, N. et al. Structural basis for perception of diverse chemical substances by T1r taste receptors. Nat. Commun. 8, 15530 (2017).
287. Maeda, S. et al. Development of an antibody fragment that stabilizes GPCR/G-protein complexes. Nat. Commun. 9, 3712 (2018).
288. Safdari, H. A. et al. Illuminating GPCR Signaling by Cryo-EM. Trends Cell Biol. 28, 591–594 (2018).
289. Strehlitz, B., Nikolaus, N. & Stoltenburg, R. Protein detection with aptamer biosensors. Sensors 8, 4296–4307 (2008).
290. Bunka, D. H. J., Platonova, O. & Stockley, P. G. Development of aptamer therapeutics. Curr. Opin. Pharmacol. 10, 557–562 (2010).
291. Skerra, A. Engineered protein scaffolds for molecular recognition. J. Mol. Recognit. 13, 409–409 (2000).
292. Clark, A. A. et al. Extraoral bitter taste receptors as mediators of off-target drug effects. FASEB J. 26, 4827–4831 (2012).
293. Le Poul, E. et al. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 278, 25481–25489 (2003).
294. Liu, D. et al. Expression of the candidate fat taste receptors in human fungiform papillae and the association with fat taste function. Br. J. Nutr. 120, 64–73 (2018).
295. Nohr, M. K. et al. GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells versus FFAR3 in enteric neurons and FFAR2 in enteric leukocytes. Endocrinology 154, 3552–3564 (2013).
296. Tang, C. et al. Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2diabetes. Nat. Med. 21, 173–177 (2015). This study posits that FFAR2 and FFAR3 antagonists might be beneficial for patients with diabetes, as deletion of both receptors in pancreatic β-cells increases insulin secretion and improves glucose tolerance in mice with type 2 diabetes.
297. Brown, A. J. et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278, 11312–11319 (2003).
298. Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569–573 (2013).
299. Trompette, A. et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat. Med. 20, 159–166 (2014). The study provides evidence that circulating short-chain fatty acids, which are produced by fermentation of dietary fibres by gut microbiota, activate the bone marrow–lung axis to control allergic airway inflammation.
300. Maslowski, K. M. et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282–1286 (2009).
301. Hong, Y. H. et al. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 146, 5092–5099 (2005).
302. De Vadder, F. et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156, 84–96 (2014).
303. Kimura, I. et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc. Natl Acad. Sci. USA 108, 8030–8035 (2011).
304. Kimura, I. et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4, 1829 (2013).
305. Cani, P. D. et al. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes 55, 1484–1490 (2006).
306. Steensels, S. et al. Supplementation of oligofructose, but not sucralose, decreases high-fat diet induced body weight gain in mice independent of gustducin-mediated gut hormone release. Mol. Nutr. Food Res. 61, 1600716 (2016).
307. Chambers, E. S. et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64, 1744–1754 (2015). This study describes a novel dietary strategy increasing propionate levels in the colon, with favourable effects on appetite regulation and body weight management in overweight adults.
308. Pingitore, A. et al. The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. Diabetes Obes. Metab 19, 257–265 (2017).
309. Nicolucci, A. C. et al. Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity. Gastroenterology 153, 711–722 (2017).
310. Sina, C. et al. G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation. J. Immunol. 183, 7514–7522 (2009).
311. Vermeire, S. et al. GLPG0974, an FFA2 antagonist, in ulcerative colitis: efficacy and safety in a multicenter proof-of-concept study. J. Crohns Colitis 9, S39 (2015).
312. Denda, M. Newly discovered olfactory receptors in epidermal keratinocytes are associated with proliferation, migration, and re-epithelialization of keratinocytes. J. Invest. Dermatol. 134, 2677–2679 (2014).
313. Pavan, B. & Dalpiaz, A. Odorants could elicit repair processes in melanized neuronal and skin cells. Neural Regen. Res. 12, 1401–1404 (2017).
314. Santha, S. & Dwivedi, C. Anticancer effects of Sandalwood (Santalum album). Anticancer Res. 35, 3137–3145 (2015).
315. Gerspach, A. C., Steinert, R. E., Schonenberger, L., Graber-Maier, A. & Beglinger, C. The role of the gut sweet taste receptor in regulating GLP-1, PYY, and CCK release in humans. Am. J. Physiol. Endocrinol. Metab. 301, E317–E325 (2011).
316. Steinert, R. E. et al. The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). Clin. Nutr. 30, 524–532 (2011).
317. Chang, A. J. et al. The role of Olfr78 in the breathing circuit of mice. Nature 562, E41 (2018).